Buzzetti R, Gamba T, Pedrini P, Carrara I, Marinoni G. Quante persone hanno avuto l’infezione da Covid-19? Un’indagine nella provincia di Bergamo. Ricerca&Pratica, 2020;37(2):69-70
Articolo
-
-
Majo F, Buzzetti R, Cigana C. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura: DOXYCYCLINE IMPROVES CLINICAL OUTCOMES DURING CYSTIC FIBROSIS EXACERBATIONS. Orizzonti FC, 2019;16(1):29-33
-
Cirilli N, Buzzetti R, Costa S, Magrì M, Graziano L, Cialfi S, Alghisi F, Majo F, Ficili F, Magazzù G, Samaja M, on behalf of IPaCOR Working Group. Cataloguing outcome measures of cystic fibrosis clinical studies. Journal of Cystic Fibrosis, 2019;S135
-
Terlizzi V, Mergni G, Buzzetti R, Centrone C, Zavataro L, Braggion C. Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy. Journal of Cystic Fibrosis, 2019;Jul;18(4):484-490
-
Chindamo S, Buja A, DeBattisti E, Terraneo A, Marini E, Gomez Perez LJ, Marconi L, Baldo V, Chiamenti G, Doria M, Ceschin F, Malorgio E, Tommasi M, Sperotto M, Buzzetti R, Gallimberti L. Sleep and new media usage in toddlers. Eur J Pediatr, 2019;Apr 178(4):483-490
-
Salvatore D, Padoan R, Buzzetti R, Amato A, Giordani B, Ferrari G, Majo F. Patients with cystic fibrosis having a residual function mutation: Data from the Italian registry. Pediatr Pulmonol, 2019;54(2):150-157
-
Parisi GF, Buzzetti R, Farina C. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura: COMBINED ANTIFUNGAL THERAPY IS SUPERIOR TO MONOTHERAPY IN PULMONARY SCEDOSPORIOSIS IN CYSTIC FIBROSIS. Orizzonti FC, 2019;16(3):39-46
-
Parisi GF, Buzzetti R, Ferrera L. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura: INHALED HYPERTONIC SALINE IN PRESCHOOL CHILDREN WITH CYSTIC FIBROSIS (SHIP): A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Orizzonti FC, 2019;16(3):35-38
-
Galici V, Buzzetti R, Braggion C. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura: IMPROVEMENT IN EXERCISE DURATION, LUNG FUNCTION AND WELL-BEING IN G551D-CYSTIC FIBROSIS PATIENTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CROSS-OVER STUDY WITH IVACAFTOR TREATMENT. Orizzonti FC, 2019;16(2):30-33
-
Galici V, Buzzetti R, Bacci G. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura: BOLUS WEEKLY VITAMIN D3 SUPPLEMENTATION IMPACTS GUT AND AIRWAY MICROBIOTA IN ADULTS WITH CYSTIC FIBROSIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL. Orizzonti FC, 2019;16(2):27-30
© 2022 Roberto Buzzetti - P. iva: 02926830163 - Developed by Onlime